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circulatory disturbance was found on the ﬁ rst day of the week, on Monday, with a 
gradually decreasing tendency towards the end of the week. Examination of variation 
according to age groups showed a signiﬁ cant difference only in case of TIA with con-
sideration to daily variation. CONCLUSIONS: The decrease is higher from Friday to
Sunday. In summary, the results of our study show that the incidence of an acute
myocardial infarction and a transient ischemic attack shows characteristic variation
with regard to seasons and the days of the week.
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OBJECTIVES: Atherosclerotic disease is the leading cause of mortality in the US.
Modiﬁ able and non-modiﬁ able risk factors need to be studied simultaneously for
stroke and coronary artery disease (CAD). We examined the association between daily 
alcohol consumption, race/ethnicity, stroke and CAD. METHODS: We used the 2005 
Behavioral Risk Factor Surveillance System (BRFSS), a nationally representative cross-
sectional survey. We performed Chi-square tests to determine associations between 
daily alcohol consumption (1, 1–2, and 2 drinks) and race/ethnicity (Black, Asian,
Native Hawaiian/Paciﬁ c Islander, American Indian/Alaskan Native, White, Hispanic, 
Multiracial, and Other) with stroke and CAD. Identifying daily alcohol consumption
and race/ethnicity as independent variables and stroke or CAD as dependent variables, 
we assessed the relationships in multivariate logistic regression after controlling for
modiﬁ able and non-modiﬁ able risk factors. Modiﬁ able risk factors included hyperten-
sion, hyperlipidemia, diabetes, body mass index, exercise, daily fruit/vegetable con-
sumption, smoking status, education, and income. Non-modiﬁ able risk factors 
included gender and age. RESULTS: We analyzed 269,554 cases. Compared to those
having 2 drinks/day, individuals who reported 1 drink/day were found to have 1.36 
[95%CI  1.14–1.63] greater odds of stroke [p  0.001] and 1.33 [95%CI  1.17–
1.51] greater odds of CAD [p  0.0001]. For stroke and CAD, American Indians/
Alaskan Natives had 1.65 [95%CIs  1.41–1.94] and 1.41 [95%CI  1.24–1.62] 
greater odds, respectively, than Whites [p  0.0001 each]. Hispanics had 0.70 [95%CI
 0.62–0.79] lower odds of stroke [p  0.0001] while Blacks had 1.18 [95%CI 
1.08–1.28] greater odds [p  0.0001] than Whites. Blacks had 0.76 [95%CI  0.70–
0.82] and Asians had 0.74 [95%CI  0.61–0.90] lower odds of CAD than Whites [p 
 0.0001 each]. CONCLUSIONS: Although there are similar ﬁ ndings between those
having 1–2 and 2 drinks/day, we do not advise drinking above the dietary guidelines; 
other information does not support this action. We note existing literature supports
a beneﬁ cial effect of having 1–2 drinks/day compared to 1 on stroke and CAD.
Race/ethnicity is strongly associated with stroke and CAD.
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OBJECTIVES: Worldwide, the association of passive smoking with development of 
stroke has been ascertained. However, it remains unknown of the magnitude of the 
association in the Chinese population. We thus systematically reviewed the published 
studies worldwide. METHODS: We searched Medline, EMBASE, and three other 
Chinese databases from their inception to June, 2008. We included case-control and
cohort studies that investigated the association of smoking with stroke, and that pro-
vided data on the magnitude of the association. Two reviewers screened the eligibility,
assessed the extent of the bias, and extracted data independently. We obtained the 
unadjusted and adjusted estimates of studies. We pooled the trial data using the
random-effect model and explored the heterogeneity by the pre-speciﬁ ed variables. 
RESULTS: We included 49 studies (n  58,872), 8 of which were cohort studies (n 
42,755) and 41 case-control studies (cumulative cases 7 883, controls 9 590). Smoking 
increased the risk of stroke by 75% (OR 1.75, 95%CI 1.51 to 2.03). Pooling of 
adjusted estimates of 31 studies (n  26,028) showed the risk of stroke was increased
by 81% in smokers (1.81, 1.57 to 2.08). The magnitude of the association was not
statistically different in different type of strokes: hemorrhagic stroke 1.65 (1.29 to 
2.11) and ischemic stroke 1.79 (1.20 to 2.68). No dose-response relationship was
found between amount of smoking and the risk of stroke. CONCLUSIONS: The 
increased risk of stroke associated with smoking in the Chinese population has been 
ascertained.
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OBJECTIVES: To analyze the health care utilization and risk proﬁ les of patients 
with metabolic syndrome (MS) based on subgroups identiﬁ ed by a latent class 
analysis. METHODS: Utilizing the medical record database from GE Healthcare, we
estimate a set of regressions to take a closer look at the effect of metabolic syndrome 
(MS) on patients’ hospital admission, ofﬁ ce visit, and the risk of developing one par-
ticular type of cardiovascular disease, coronary heart disease (CHD). Patients are 
identiﬁ ed as having MS by using the guidelines proposed by the National Cholesterol 
Education Program Adult Treatment Panel III. We conduct the analysis in this study 
in the following steps; ﬁ rst, we adopt negative binominal regression models to estimate
the effect of MS on hospital admission and ofﬁ ce visit; second, Probit models are 
applied to examine the relationship between MS and CHD; and third, the results from 
the Latent Class Analysis, which identiﬁ es ﬁ ve subgroups of MS patients by risk 
factors, are integrated into the regression estimations. RESULTS: We ﬁ nd 1) that
patients with MS have higher number of hospital admissions and ofﬁ ce visits, and
are more likely to develop CHD than those without MS, and 2) that MS patients 
with abnormal blood pressure are more likely to be hospitalized than MS patients
with normal blood pressure. Strikingly, we ﬁ nd, by integrating the results from a 
latent class analysis, that MS patients with the simultaneous presence of three risk
factors, abnormal HDL, waist circumference, and blood pressure, are more likely to 
develop CHD than other types of MS patients. CONCLUSIONS: LCA offers a useful
method to help better classify MS patients into sub groups by shared group-speciﬁ c 
characteristics that would be hard to measure otherwise. Based on the LCA study, we 
conﬁ rm that MS patients with multiple risk factors are more likely to develop CHD 
conditions.
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Atrial ﬁ brillation (AF) poses a substantial health burden. While analyses of the 
AFFIRM study showed that maintenance of sinus rhythm (SR) reduced the risk of 
stroke and death, due to their toxicity, antiarrhythmic drug (AAD) use was found to
be independently associated with increased mortality. OBJECTIVES: To estimate the 
beneﬁ ts of SR maintenance, in order to understand the potential improvements of 
maintaining SR with alternatives to AADs, such as ablation. METHODS: A discrete 
event simulation (DES) was developed predicting stroke and death in a population
with AF using equations from AFFIRM. Individual patients were created and assigned 
unique attributes. Analyses were run over a ten year time horizon, wherein the AF
burden (the time spent out of SR) was allowed to vary from 0 to 50%. Scenarios were
evaluated wherein SR was attained with and without use of AADs. RESULTS: Under 
the assumption of perfect rhythm control, 17.1% of patients controlled with AADs
were predicted to die, compared to only 12.8% of those controlled without AADs;
5.9% and 6.2% of these populations were predicted to have strokes, respectively. 
Strokes were higher in latter cohort because of improved survival. When the AF 
burden was increased to 25%, 19.5% and 14.6% were predicted to die, while 6.6% 
and 6.8% were predicted to have a stroke, respectively. A further increase of the AF
burden to 50% resulted in predicted mortality of 22.1% and 16.7%, and stroke rates
of 7.2% and 7.6%, respectively. CONCLUSIONS: Maintenance of SR improves sur-
vival in patients with AF, and without the use of AAD was predicted to yield a sub-
stantial incremental survival beneﬁ t. These results indicate that techniques like
ablation, which have been shown to be more effective than AAD for converting and
maintaining SR would have important beneﬁ ts in an AF population.
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OBJECTIVES: To assess the clinical impact of disagreement between two methods of 
measuring INR in our anticoagulation clinics. METHODS: We assessed paired INR 
samples collected from the same patient at the same visit from 4 anticoagulation clinics 
associated with the Johns Hopkins Medical Institutions. One venous sample was 
analyzed in the Johns Hopkins Coagulation Laboratory and one ﬁ ngerstick sample
was analyzed by the Hemochron Signature Plus POC device (International Techni-
dyne Corporation, Edison, NJ, USA). A newly-developed analytic technique was
applied that reports results in explicitly clinical terms. RESULTS: Samples were col-
lected from 1666 patients from January, 2006 through June, 2008. The lab was nearly
twice as likely to report a value below the target INR range of 2–3 compared with 
the POC (36% vs. 19%). Furthermore, the lab was almost four times more likely to 
report that the INR was 1.0–1.49 – a range associated with a 13.5-fold increased risk 
of a thromboembolic event (18% vs. 5%). Overall, 29% of clinical decisions were 
projected to differ, depending on which measure was used. A majority (53%) of the
predicted clinical differences occurred when the POC device reported a value within 
the target INR range. Based on epidemiologic evidence of risk as a function of the
INR, we estimate that 67 thromboembolic events occurred over the 2.5 year period 
because of the discrepancy between the measures. CONCLUSIONS: There are clini-
cally relevant differences between INR values reported by the Hemochron POC device
and our clinical lab that were not detected by conventional methods. The Hemochron
device biases INR measures towrd the target range throughout the INR scale. This 
bias prevents many necessary warfarin dosing changes because the clinician does not 
understand the patient’s true risk level. Therefore, patients spend more time at INR 
levels strongly associated with an increased risk of a negative outcome.
